Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

February 26, 2020

Study Completion Date

November 22, 2022

Conditions
Emphysema
Interventions
DEVICE

Endobronchial Coils

Endobronchial Coil implants

Trial Locations (19)

34376

Lungenfachklinik Immenhausen, Immenhausen

51092

CHU de Reims - Hopital Maison Blanche, Reims

67091

Nouvel Hôpital Civil, Strasbourg

Unknown

Ludwig Boltzmann Institut Fur COPD und pneumologische Epidemologie, Vienna

CHU Grenoble, Grenoble

CHU Montpellier, Montpellier

Hôpital Bichat, Paris

Charite Berlin - Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Berlin

Gemeinschaftskrankenhaus Havelhöhe GmbH, Berlin

Universitätsklinkum Bonn, Bonn

Ruhrlandklinik Essen, Essen

Thoraxklinik, Heidelberg

Lungenklinik, Hemer

Klinikverbund Kempten-Oberallgäu, Immenstädt

Krankenhaus vom Roten Kreuz Bad Cannstatt GmbH, Stuttgart

Ospedale Careggi, Florence

Royal Brompton Hospital, London

CS 51069

Centre Hospitalier Universitaire de Nice, Nice

3150-3610536

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PneumRx, Inc.

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY

NCT03360396 - Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema | Biotech Hunter | Biotech Hunter